![Fred Porter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Fred Porter currently works at Taysha Gene Therapies, Inc., as Chief of Staff & Technical Operations Officer from 2020.
Dr. Porter also formerly worked at BridgeBio Pharma, Inc., as SVP-Technical Development & Manufacturing from 2018 to 2020.
Aktive Positionen von Fred Porter
| Unternehmen | Position | Beginn |
|---|---|---|
| TAYSHA GENE THERAPIES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2020 |
Ehemalige bekannte Positionen von Fred Porter
| Unternehmen | Position | Ende |
|---|---|---|
| BRIDGEBIO PHARMA, INC. | Corporate Officer/Principal | 01.08.2020 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
3
Beziehungen ersten Grades
2
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
BridgeBio Pharma, Inc.
 BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
Taysha Gene Therapies, Inc.
 Taysha Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes adeno-associated viruses-based gene therapies for the treatment of monogenic diseases of the central nervous system | Health Technology |
